The global surgical masks market size was USD 4.02 Billion in 2022 and is expected to register a revenue CAGR of 10.9% during the forecast period.
- Emergence of different types of diseases followed by an increase in the number of surgeries or operations conducted globally is expected to boost demand for surgical masks over the forecast period.
- The cotton segment is expected to register a fast revenue growth rate during the forecast period.
- The polypropylene (PP) segment is expected to register considerable revenue share in the global market during the forecast period.
- The basic surgical mask segment is expected to account for largest revenue share over the forecast period
- The fluid/splash-resistant surgical mask segment is expected to register a considerably robust revenue growth rate over the forecast period.
- The offline segment is expected to register a fast revenue growth rate during the forecast period.
Request a Sample@ https://www.qyresearchmedical.com/sample/119584
Report Scope of the Surgical Masks Market:
|The market size value in 2022||USD 4.02 Billion|
|CAGR (2023 – 2032)||10.9%|
|The Revenue forecast in 2032||USD 10.20 Billion|
|Quantitative units||Revenue in USD Billion
CAGR from 2023 to 2032
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
Increasing need for preventing the spread of viral infections, growing need to prevent the transfer of droplets, splashes, and sprays in healthcare settings, and increasing need to mitigate exposure to particulate air pollution are key factors driving the global surgical masks market revenue growth.
Countries are stockpiling face masks in preparation for antiviral interventions during an influenza pandemic. The COVID-19 pandemic caused severe economic damage primarily due to a drop in demand for a range of products and services. According to a data, the global GDP declined by 4.5% in 2020, almost USD 2.96 Trillion in lost economic output. A pandemic of influenza or other respiratory diseases such as Severe Acute Respiratory Syndrome (SARS) can result in shortages of masks, antiviral drugs, or delayed delivery of vaccines. Thus, non-pharmacological interventions such as masks, handwashing, and other hygiene measures, could be effective early control measures. According to a survey in 2020, 15% of U.S. adults are extremely concerned about SARS. The usage of a mask was linked to a lower risk of infection from influenza-like illness (ILI). The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) recommend using surgical masks to prevent the transmission of Coronavirus and other airborne diseases. On 8 April 2022, The WHO evaluated the safety and effectiveness of the following vaccines against COVID-19. In addition to reducing influenza virus RNA detection in respiratory droplets, surgical face masks also lowered Coronavirus RNA detection in aerosols, with a tendency toward reducing coronavirus RNA detection in respiratory droplets. Virus infections of the respiratory system resulting in wide-ranging symptoms known as Acute Respiratory Viruses Illnesses (ARIs). As a result, surgical masks are important for preventing the transfer of viruses. Some health authorities advise the use of masks to prevent forward transmission, which is expected to boost demand for surgical masks.
Infectious diseases are common among health workers. Thus, use of a surgical face mask is essential to control the spread of infections, especially when avoiding the transmission of droplets. For instance, on 5 June 2020, the WHO updated the guidelines regarding mask-wearing. The World Health Organization recommended surgical masks for every clinical work in a health facility, along with those dealing with COVID-19 patients. The WHO instructs people aged 60 and older, and those with underlying medical conditions, should wear a surgical mask in areas with community transmission where physical distancing is not possible. Customers have increasingly been turning to surgical face masks due to rising pollution levels and air-borne diseases. According to a data, surgical face masks are 68% effective in blocking the spread of SARS. In addition, geriatric patients with chronic conditions are more susceptible to infectious diseases, such as COVID-19 along with their health-related problems, leading to surgeries, are expected to drive demand for surgical masks among them.
Competitive landscape of the global surgical masks market is fairly fragmented with many key players operating on global and regional levels. Key players are engaged in product development and strategic alliances to expand their respective product portfolios and gain a robust footing in the global market. Major companies in the market include The 3M Company, DuPont de Nemours, Inc., Kimberly-Clark Corporation, Medline Industries, LP, Crosstex International, Inc., Alpha ProTech, Dynarex Corporation, O&M Halyard, Prestige Ameritech, Ansell Ltd., Cardinal Health, and Ambu A/S.
Surgical Masks Market Segmentations:
|By Material Type Outlook||By Product Type Outlook||By Distribution Channel Outlook||By End-use Outlook|
Basic Surgical Mask
Anti-fog Surgical Mask
Fluid/Splash Resistant Surgical Mask
|Hospitals & Clinics
Industrial & Institutional
Buy quantitative research Report at discounted price – USD 1599 https://www.qyresearchmedical.com/report/checkout/119584/
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: